<?xml version="1.0" encoding="UTF-8"?>
<p>Finally, stakeholder engagement should not exclude scientists in the country or region who have experience leading clinical trials during health disasters, such as those involved with the design and implementation of the Ebola ring vaccine trial in West Africa in 2014, which proved a game changer in ending the outbreak. Stakeholders should also include the private sector and philanthropists who have played significant roles in the containment of the COVID‐19 pandemic in the region.
 <fn id="dewb12283-note-1057">
  <label>57</label>
  <p>Connecting Business Initiative. (2020, 15 May). Connecting Business initiative response to COVID‐19: Transforming private sector engagement in crises. Retrieved June 6, 2020, from 
   <ext-link ext-link-type="uri" xlink:href="https://reliefweb.int/report/world/connecting-business-initiative-response-covid-19-transforming-private-sector-engagement" xmlns:xlink="http://www.w3.org/1999/xlink">https://reliefweb.int/report/world/connecting‐business‐initiative‐response‐covid‐19‐transforming‐private‐sector‐engagement</ext-link>. Accessed:
  </p>
 </fn> Africa is not new to the conduct of clinical trials, and it has made successes of many of the clinical trials conducted on the continent through robust stakeholder engagement.
 <fn id="dewb12283-note-1058">
  <label>58</label>
  <p>Baker, &amp; Mizrahi, op. cit. note 3.</p>
 </fn>
</p>
